Publicaciones (18) Publicaciones de MARTA MOYA MONTES

2024

  1. Bacterial lipopolysaccharide forms aggregates with apolipoproteins in male and female rat brains after ethanol binges

    Journal of Lipid Research, Vol. 65, Núm. 3

2023

  1. Reelin Plasma Levels Identify Cognitive Decline in Alcohol Use Disorder Patients During Early Abstinence: The Influence of APOE4 Expression

    The international journal of neuropsychopharmacology, Vol. 26, Núm. 8, pp. 545-556

  2. Treatment with Adalimumab 80 mg Every Other Week in Inflammatory Bowel Disease: Results of Treatment Intensification in Clinical Practice

    Crohn's and Colitis 360, Vol. 5, Núm. 1

2022

  1. Disinhibition-Like Behavior Correlates with Frontal Cortex Damage in an Animal Model of Chronic Alcohol Consumption and Thiamine Deficiency

    Biomedicines, Vol. 10, Núm. 2

  2. Oleoylethanolamide attenuates the stress-mediated potentiation of rewarding properties of cocaine associated with an increased TLR4 proinflammatory response

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 124

  3. Upregulation of TLR4/MyD88 pathway in alcohol-induced Wernicke’s encephalopathy: Findings in preclinical models and in a postmortem human case

    Frontiers in Pharmacology, Vol. 13

2021

  1. Cerebellar and cortical TLR4 activation and behavioral impairments in Wernicke-Korsakoff Syndrome: Pharmacological effects of oleoylethanolamide

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 108

  2. Effects of Alcohol Binge Drinking and Oleoylethanolamide Pretreatment in the Gut Microbiota

    Frontiers in Cellular and Infection Microbiology, Vol. 11

2014

  1. A simple transcriptomic signature able to predict drug-induced hepatic steatosis

    Archives of Toxicology, Vol. 88, Núm. 4, pp. 967-982

2013

  1. The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPARα; And repressed by C/EBPα: Implications in FABP1 down-regulation in nonalcoholic fatty liver disease

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1831, Núm. 4, pp. 803-818

2012

  1. Altered glucose-stimulated insulin secretion in a mouse line with activated polyamine catabolism

    Transgenic Research, Vol. 21, Núm. 4, pp. 843-853

  2. Foxa1 reduces lipid accumulation in human hepatocytes and is down-regulated in nonalcoholic fatty liver

    PLoS ONE, Vol. 7, Núm. 1

  3. Vascular endothelial growth factor-mediated islet hypervascularization and inflammation contribute to progressive reduction of β-cell mass

    Diabetes, Vol. 61, Núm. 11, pp. 2851-2861

2010

  1. Enhanced steatosis by nuclear receptor ligands: A study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile

    Chemico-Biological Interactions, Vol. 184, Núm. 3, pp. 376-387

  2. Interaction between Hhex and SOX13 modulates Wnt/TCF activity

    Journal of Biological Chemistry, Vol. 285, Núm. 8, pp. 5726-5737

2009

  1. Transcriptional regulation of cytochrome P450 genes by the nuclear receptor hepatocyte nuclear factor 4-alpha

    Current Drug Metabolism, Vol. 10, Núm. 5, pp. 508-519

2006

  1. Expression of IGF-I in pancreatic islets prevents lymphocytic infiltration and protects mice from type 1 diabetes

    Diabetes, Vol. 55, Núm. 12, pp. 3246-3255

  2. In vivo gene transfer to healthy and diabetic canine pancreas

    Molecular Therapy, Vol. 13, Núm. 4, pp. 747-755